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Abstract: We proposed to measure the metabolic rate of oxygen (MRO2) in 
small animals in vivo using a multimodal imaging system that combines 
laser-scanning  optical-resolution  photoacoustic  microscopy  (LSOR-PAM) 
and  spectral-domain  optical  coherence  tomography  (SD-OCT).  We  first 
tested the capability of the multimodal system to measure flow rate in a 
phantom  made  of  two  capillary  tubes  of  different  diameters.  We  then 
demonstrated the capability of measuring MRO2 by imaging two parallel 
vessels selected from the ear of a Swiss Webster mouse. The hemoglobin 
oxygen  saturation  (sO2)  and  the  vessel  diameter  were  measured  by  the 
LSOR-PAM and the blood flow velocity was measured by the SD-OCT, 
from  which  blood  flow  rate  and  MRO2  were  further  calculated.  The 
measured blood flow rates in the two vessels agreed with each other. 
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1. Introduction 
Studying  microcirculation  in  the  retina  plays  an  important  role  in  ophthalmic  research. 
Because the retina is a highly energy-demanding tissue, an abnormal oxygen supply may lead 
to several vision disorders. For example, retinal degeneration [1], diabetic retinopathy [2] and 
retinopathy of prematurity [3] have been reported to be correlated with disrupted local retinal 
oxygen  environments,  which  can  be  quantified  by  intraretinal  oxygen  distribution  and 
metabolic rate of oxygen (MRO2, also can be referred to oxygen consumption). Hence, a 
technology that is able to measure MRO2 in the retina is desired. Such a technology should 
possess the following characteristics: (1) noninvasiveness; (2) label-free; (3) fast-acquisition; 
(4) high-spatial resolution, and (5) capable of measuring multiple functional parameters, such 
as  hemoglobin  oxygen  saturation  (sO2)  and  blood  flow;  however,  no  existing  technology 
satisfies all the above requirements. 
Currently, measuring retinal MRO2 primarily relies on oxygen-sensitive microelectrodes 
[1,2], which is not only invasive but also terminal. Blood-oxygen-level-dependent contrast 
MRI  has  also  been  used  to  measure  ocular  MRO2;  however,  its  spatial  resolution  is 
insufficient in microcirculation studies [4,5]. Fundus photography-based retinal oximetry has 
the potential to quantify sO2 [6,7] and several optical coherence tomography (OCT) based 
technologies have been reported to measure retinal blood flow [8–12]; but each individual 
technology is insufficient to measure MRO2 as both sO2 and blood flow measurements are 
required. 
Here, we demonstrate the feasibility of measuring MRO2 at the microvascular level in vivo 
without  extrinsic  contrast  agent  using  a  combined  laser-scanning  optical-resolution 
photoacoustic microscopy (LSOR-PAM) and spectral-domain OCT (SD-OCT). 
2. Methods and materials 
To measure the MRO2 in vivo, we selected an artery-vein pair and acquired the following 
parameters:  the  sO2  in  artery  and  vein  (sO2a  and  sO2v,  dimensionless),  the  mean  total 
hemoglobin concentration (HbT, g/L) in blood, the diameters of the artery and vein (da and 
dv, m), and the mean blood flow velocities in the artery and vein ( a v  and v v , m/s). Assuming 
that vessels have circular cross-sections, total hemoglobin concentration is constant, and each 
hemoglobin molecule carries four oxygen molecules, the MRO2 (g/min) is given by 
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where WO2 and WHbO2 are the molecular weights of O2 and oxy-hemoglobin, which are 32 and 
68000, respectively. 
In Eq. (1), the sO2 was calculated based on multi-wavelength LSOR-PAM measurements 
[13–15]. The HbT was measured from blood samples by a commercial veterinary laboratory. 
The diameters of the blood vessels were measured by LSOR-PAM along the lateral direction. 
The mean blood flow velocity was measured by the SD-OCT based on [8] 
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where fsample is the  A-line rate; λ0 is the central  wavelength of the probing light; n is the 
refractive index of sample (~1.4 for soft tissue and ~1.33 for water); ∆φ is the unwrapped 
phase shift between adjacent A-lines which ranged in [-π, + π]; and θ is the OCT Doppler 
angle (the angle between incident probing light and the blood vessel flow direction). 
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Fig. 1. Schematics of the combined LSOR-PAM and SD-OCT. PD: photodiode; 2 × 2: 2 × 2 
single-mode optical fiber coupler; HM: hot mirror; GM: 2D galvanometer; OBJ: objective lens; 
AMP: amplifier; UT: ultrasonic transducer; WT: water tank; SLED: superluminescent emitting 
diode; Ref: OCT reference arm. 
The schematic of the integrated LSOR-PAM and SD-OCT is shown in Fig. 1. The optical 
illumination  and  ultrasonic  detection  in  the  LSOR-PAM  have  been  described  elsewhere 
[16,17]. To brief, we used a tunable dye laser (Cobra, Sirah Laser and Plasmatchnik GmbH) 
pumped by a Nd:YLF laser (IS8II-E, Edge-Wave GmbH; pulse duration: 6 ns; repetition rate: 
1024 Hz) as the irradiation source. The dye laser output was coupled into a single mode 
optical fiber and was then merged with the OCT probing light by a dichroic mirror (NT43-
955, Edmund Optics). The combined beams were scanned by an x–y galvanometer (6230H, 
Cambridge Technology) and were focused by an achromatic lens with 40-mm focal length 
(AC254-040-A1, Thorlabs). We used four optical wavelengths (570 nm, 578 nm, 588 nm, and 
590 nm) in the multiwavelength measurement for sO2. 
A  custom-built  unfocused  needle  ultrasonic  transducer  (center  frequency:  35  MHz; 
bandwidth: 50%; active element size: 0.5 × 0.5 mm
2) was used to detect the PA waves. The 
detected PA signals were amplified by 49 dB and were digitized by a high speed digitizer (CS 
14200, Gage Applied) at a sampling rate of 200 MS/s. The energy of each laser pulse was 
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instability. As reported in our previous work, the lateral resolution of the LSOR-PAM is 2.8 
µm, and the axial resolution is 23 µm [18]. 
The SD-OCT system used a broadband superluminescent emitting diode (SLED) as the 
light source (IPSDD0804, InPhenix; center wavelength λ0: 840 nm; 3-dB bandwidth ∆λ: 50 
nm). The output light was coupled into a 2 × 2 single-mode optical ﬁber coupler after being 
attenuated by 3 dB. A home-made spectrometer was used to detect the interference light with 
an  A-line  rate  (fsample)  of  24  kHz.  The  axial  resolution  is  6  µm  in  tissue  and  the  lateral 
resolution is 20 µm [17]. In order to measure flow, the animal holder and the water tank were 
both tilted by an angle (quantified in the acquired 3D OCT images) as shown in Fig. 1. 
A  flow  phantom  was  made  of  two  polystyrene  capillary  tubes  (CTPS125-250-5  and 
CTPS250-500-5, Paradigmoptics; inner diameters: 125 µm and 250 µm; outer diameters: 250 
µm  and  500  µm).  The  two  tubes  were  glued  interconnected  and  the  thinner  tube  was 
connected to a perfusion pump (A-99, Razel) for flow control. As a result, the two tubes have 
identical flow rate but different flow velocity. Diluted red ink (10%) mixed with 1% Intralipid 
solution was used to mimic blood. The two tubes were placed in parallel at the bottom of the 
water tank and were tilted by 5.6° with respect to the OCT probing light. 
In the in vivo experiment, a Swiss Webster mouse (Harlan Co.; body weight: 20 g) ear was 
imaged. The animal was anesthetized by a mixture of 1.5% isoﬂurane and regular air. After 
hairs were removed by a commercial nonirritating hair-removing lotion, the animal was fixed 
on a homemade animal holder during the imaging period. The mouse ear was placed on a flat 
supporter and the supporter was tilted by 3.8° with respect to the OCT probing light. The 
mouse  was  sacrificed  after  data  acquisition  and  blood  samples  were  taken  for  HbT 
measurement.  All  experimental  animal  procedures  conformed  to  the  laboratory  animal 
protocol approved by the Animal Care and Use Committee of the University of Wisconsin–
Milwaukee, where the experiments were conducted. 
3. Results and discussions 
3.1. Flow phantom results 
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Fig. 2. Flow phantom imaging results. (a) LSOR-PAM image of the tubes (mean intensity 
projection);  (b)  PA  amplitude  profile  along  the  dashed  line  in  panel  a;  (c)  flow  velocity 
measured by Doppler OCT at the cross section marked in panel a; (d) the flow velocity profile 
at locations marked by the two dash lines in panel c. Bar: 250 µm. 
Figure  2  shows  the  phantom  imaging  results.  Figure  2a  is  the  LSOR-PAM  mean-
amplitude-projection image of the capillary tubes acquired at the optical wavelength of 570 
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image are measured to be 4.8° (left) and 2.4° (right), which were used to correct the measured 
tube diameters. Figure 2b shows the PA amplitude (averaged for 32 times) along the dashed 
line in Fig. 2a and the tube diameter were measured to be d1 = 134.46 ± 0.98 µm (left) and d2 
= 249.83 ± 0.39 µm (right). Figure 2c shows the Doppler OCT result measured at the location 
marked in Fig. 2a. The Doppler angle was 84.4° and the calculated mean flow velocities were 
1 v  = −11.20 ± 0.32 mm/s and  2 v  = 3.40 ± 0.37 mm/s. The sign of the velocity represents the 
flow direction. 
We compared the flow rates 
2 60 4 F d v π = ⋅ ⋅ ⋅  between the two capillary tubes. The 
pump was set at flow rate of 0.595 cc/hr (9.92 µl/min); and we calculated that F1 = 9.51 ± 
0.14 µl/min and F2 = 9.94 ± 1.12 µl/min. The comparable flow rates between the two capillary 
tubes demonstrated the self-consistency in the multimodal measurement, which also agreed 
with the pump value. 
3.2. In vivo results 
To test the feasibility of measuring MRO2, the microvasculature in mouse ears was used as an 
analogue of retinal vessels because both objects are optically thin. 
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Fig. 3. Multimodal anatomic imaging of a mouse ear. (a) LSOR-PAM projection image of an 
artery-vein pair; (b) LSOR-PAM B-Scan image acquired at the 570-nm optical wavelength at 
the location marked by the dashed line in panel a; (c) OCT B-Scan image acquired at the same 
location. A: Artery; V: Vein; Ep, epidermis; De, dermis; Ca, cartilaginous backbone; Bar: 100 
µm. 
Figure 3 shows the in vivo anatomic images. The mean-amplitude-projection image of two 
parallel vessels (an artery-vein pair) is shown in Fig. 3a. The quantification of sO2 and blood 
flow in these two vessels was performed in B-scan images at the location highlighted by the 
dashed line. Figure 3b shows the PAM B-scan image acquired at 570 nm after being averaged 
over 256 consecutive B-scans, where the two vessels are clearly dominating. Figure 3c shows 
the  corresponding  OCT  B-scan  image  at  the  same  location,  where  skin  anatomy  and  the 
cartilage layer are visualized but not the blood vessels. However, the shadows created by the 
vessel pair can be observed. 
Figure 4 shows the functional imaging results. The sO2 values were calculated based on 
the B-scan images acquired at the four optical wavelengths after a 3 × 3 spatial averaging in 
each  B-scan  image  and  only  the  peak  PA  amplitudes  of  the  two  vessels  were  used.  The 
measured sO2 distinguished the artery (sO2a = 68.9%) and vein (sO2v = 38.3%) in the vessel 
pair (Fig. 4a). The vessel diameters were measured to be da = 42.69 ± 0.09 µm and dv = 61.13 
± 0.25 µm using the method as we used in the flow phantom. 
Figure 4b shows the Doppler OCT results. The angle between the surface of the mouse ear 
and  the  horizontal  plane  was  3.8°;  hence,  the  Doppler  angle  was  θ  =  86.2°,  which  is 
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= −15.58 ± 0.43 mm/s and  v v  = 8.11 ± 0.48 mm/s, as shown in Fig. 4b. 
We compared the blood flow rate  in  this  vessel pair. Using the  measured blood flow 
velocities and diameters, we have Fa = 1.34 ± 0.04 µl/min and Fv = 1.43 ± 0.10 µl/min, which 
are comparable and, thus, shows that the measurements are self-consistent. 
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Fig. 4. Multimodal functional imaging. (a) Imaged sO2 using LSOR-PAM; (b) Imaged blood 
flow velocity using SD-OCT. Bar: 100 µm. 
Finally,  based  on  the  HbT  value  of  344  g/L,  the  MRO2  was  242.77  ±  30.50  ng/min, 
assuming that the vessel pair supports the same tissue volume. We want to point out here that 
MRO2  depends  on  the  subject  and  the  anatomic  sites  because  sO2  and  blood  flow  vary 
significantly between subjects and anatomic locations. 
We further converted the measured MRO2 into a more commonly used unit of liter/min. 
The ideal gas law [19] calculates the volume of oxygen (gas) from its weight by 
  / g V n RT P =    (3) 
where ng is the number of moles of gas, R is the molar gas constant 8.3145 J·mole
−1·K
−1, T is 
the blood temperature (311.15 K), and P is the standard atmosphere pressure (101,325 Pa). 
Based on the molar mass of oxygen (32 g/mol), the MRO2 is 193.70 ± 24.33 nl/min. 
In  the  current  study,  the  blood  flow  velocity  was  measured  by  SD-OCT.  Although 
transverse blood flow velocity can be measured by both amplitude-modulated continuous-
wave  and  pulsed  illuminating  PAM  [20,21],  these  methods  require  extra  visible  light 
exposure,  which  is  not  preferred  in  ophthalmic  imaging.  PAM  also  has  the  potential  to 
measure HbT if one of the isosbestic optical wavelengths in the molar extinction coefficient 
spectra  of  the  oxy-  and  deoxy-hemiglobin  [15]  is  used  and  the  correlation  between  the 
hemoglobin concentration and the measured PA amplitude is calibrated. However, such a 
capability has not been reported yet and, oftentimes, the calibration is not trivial in in vivo 
studies as the actual measured PA amplitude can be affected by local optical fluence and is 
strongly sample dependent. Taking blood sample is routine in many of the existing clinical 
diagnosis and, more important, it will be much more precise. 
We need to address a few issues in the future. First, a higher SNR in the LSOR-PAM 
needs to be achieved. Since an unfocused rather than a strongly focused ultrasonic transducer 
is used to coordinate with the optical scanning for a much higher imaging speed, the SNR 
becomes worse and signal averaging is required to minimize the errors in sO2 calculation. A 
weakly  spherical  focused  ultrasonic  transducer  can  potentially  be  employed.  Second,  the 
Doppler angle was introduced by tilting the sample in this study, which was hard to control in 
patient.  A  dual-beam  OCT  can  potentially  be  used  to  avoid  tilting  the  samples  and  still 
measures the absolute blood flow velocity [22]. 
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study.  Although  missing  or  poor  optical  fluence  compensation  leads  to  a  noticeable 
measurement  inaccuracy  in  deep  tissue  [23,24],  it  is  unlikely  to  affect  the  application  in 
ophthalmology [25] since the medium between cornea and retinal vessel (vitreous humor) is 
often considered transparent, inducing minimal attenuation of light within the visible and NIR 
spectral range. 
4. Conclusion 
In conclusion, we demonstrated the feasibility of measuring MRO2 using a combined LSOR-
PAM and SD-OCT multimodal system. The multimodal imaging system was first tested in a 
flow phantom. Then in vivo measurement of MRO2 was achieved in microvessels and the 
measured  parameters  by  different  modalities  were  self-consistent.  This  work  lays  the 
foundation  for  the  next-stage  retinal  MRO2  imaging,  which  has  great  potential  in  both 
fundamental study and clinical early diagnosis of several blinding diseases. 
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